In Brief: OTC drugs of abuse testing
This article was originally published in The Tan Sheet
OTC drugs of abuse testing: House Commerce/Oversight Subcommittee hearing on FDA's policy on home drug testing services slated for Feb. 6. Witnesses likely will include FDA commissioner's office staffers. The subcommittee, chaired by Rep. Joe Barton (R-Tex.), is expected to scrutinize the agency's progress in implementing a final policy on OTC drugs of abuse tests ("The Tan Sheet" Jan. 27, p. 7)...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC